January 17, 2025
Illuccix® Receives European Approval
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 17, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the…
Pharmaceuticals, Biotechnology and Life Sciences
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 17, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the…
PORTLAND, Maine, Jan. 16, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…
Christos Richards Christos Richards appointed to Codexis Board of Directors. REDWOOD CITY, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) — Codexis,…
VANCOUVER, British Columbia, Jan. 15, 2025 (GLOBE NEWSWIRE) — Biologic Pharmamedical is proud to announce the launch of its groundbreaking…
Ad hoc announcement pursuant to Art. 53 LR Presentation to take place on January 15, 2025, at 15:00 PST /…
BOSTON, Jan. 15, 2025 (GLOBE NEWSWIRE) — Radiance Biopharma, Inc. a biotechnology company developing next generation Antibody Drug Conjugates (“ADCs”)…
– Transaction eliminates $11.2 million in debt, strengthening financial position – HUNTSVILLE, AL, Jan. 15, 2025 (GLOBE NEWSWIRE) — Serina…
Commitment to safety, quality, and sustainability aligns with ECCO’s rigorous certification standardsSANTA BARBARA, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) —…
MANKATO, Minn., Jan. 15, 2025 (GLOBE NEWSWIRE) — Digital Utilities Ventures (OTC: DUTV), a green solutions company focused on regenerative…
JENA, Germany, Jan. 15, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today…